Reach Us +44-7447-215064
Editor - DR. THIAGARAJAN VENKATESAN | Nova Southeastern Universi | 26522
ISSN: 2165-7939

Journal of Spine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page


Dr. Thiagarajan Venkatesan
Associate Research Scientist
Nova Southeastern University


I am Dr. Thiagarajan Venkatesan currently working as an Associate Research Scientist in Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, Florida, USA. I did my Ph.D in Microbiology-Botany from University of Madras, India. I have also worked as a Research Scientist in R&D in Bharat Biotech and involved in the development of recombinant human vaccine against cancer. My work involved upstream and the downstream processing of cancer related viral antigens to the pilot and large scale levels. Currently I am doing the development of therapeutic proteins against selected targets in cancers. Also I am analyzing the gene expression pattern in highly aggressive cancers. I am an Associate member of the American Association for Cancer Research. I have published research articles in international peer reviewed journals and also presented papers in National and International conferences.

Research Interest

My research interests are focused on: Prognostic and diagnostic markers and novel therapeutic targets for human cancers, development of new therapeutic molecules against cancer, cloning, expression and purification of new biologics, testing the efficacy of small molecules, natural products and therapeutic molecules against various cancers, analyzing the pathway specific gene expression profile.